ReviewSeminars in radiation oncology2011
Will nanotechnology influence targeted cancer therapy?
Review in Seminars in radiation oncology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Development and Characterization of Biocompatible Cellulose-Tetraphenylethylene Hydrazone Self-Assembling Nanomicelles with Acidity-Triggered Release of Doxorubicin for Cancer Therapy.Current issues in molecular biology · 2024Article
- Advances in Nanotechnology Development to Overcome Current Roadblocks in CAR-T Therapy for Solid Tumors.Frontiers in immunology · 2022Review
- [Uveal melanoma : Early detection as the key to successful personalized medicine].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2020Review
- Radiolabeled PET/MRI Nanoparticles for Tumor Imaging.Journal of clinical medicine · 2019Review
- Advances in the clinical translation of nanotechnology.Current opinion in biotechnology · 2017Review
- Uveal melanoma: relatively rare but deadly cancer.Eye (London, England) · 2017Review
- Nanoparticles and radiotracers: advances toward radionanomedicine.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2016Review
- Applications of nanoparticles for diagnosis and therapy of cancer.The British journal of radiology · 2015Review
- Molecular imaging of prostate cancer: translating molecular biology approaches into the clinical realm.European radiology · 2015Review
- Nanoparticles for imaging: top or flop?Radiology · 2014Review
- Near-infrared quantum dots for HER2 localization and imaging of cancer cells.International journal of nanomedicine · 2014Article
- Dawn of advanced molecular medicine: nanotechnological advancements in cancer imaging and therapy.Critical reviews in oncogenesis · 2014Review
- Surface modified multifunctional nanomedicines for simultaneous imaging and therapy of cancer.BioImpacts : BI · 2014Review
- Advances and future of Radiation Oncology.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2013Review
- Immunotoxicological impact of engineered nanomaterial exposure: mechanisms of immune cell modulation.Toxicology mechanisms and methods · 2013Review
- Intravenously delivered graphene nanosheets and multiwalled carbon nanotubes induce site-specific Th2 inflammatory responses via the IL-33/ST2 axis.International journal of nanomedicine · 2013Article
- Reversing chemoresistance of malignant glioma stem cells using gold nanoparticles.International journal of nanomedicine · 2013Article
- Prodrug strategy for PSMA-targeted delivery of TGX-221 to prostate cancer cells.Molecular pharmaceutics · 2012Article
- Can nanotechnology potentiate photodynamic therapy?Nanotechnology reviews · 2012Article
- Shining light on nanotechnology to help repair and regeneration.Biotechnology advancesReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The rapid development of techniques that enable synthesis (and manipulation) of matter on the nanometer scale and the development of new nanomaterials will play a large role in disease diagnosis and treatment, specifically in targeted cancer therapy. Targeted nanocarriers are an intriguing means to selectively deliver high concentrations of cytotoxic agents or imaging labels directly to the cancer site. Often, solubility issues and an unfavorable biodistribution can result in a suboptimal response of novel agents even though they are very potent. New nanoparticulate formulations allow simultaneous imaging and therapy ("theranostics"), which can provide a realistic means for the clinical implementation of such otherwise suboptimal formulations. In this review, we did not attempt to provide a complete overview of the rapidly enlarging field of nanotechnology in cancer; rather, we presented properties specific to nanoparticles and examples of their uses, which show their importance for targeted cancer therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.